hydralazine has been researched along with ACD-MPV in 1 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morisot, C | 1 |
| Dubos, JP | 1 |
| Kacet, N | 1 |
| Gremillet, C | 1 |
| Remy-Jardin, M | 1 |
| Lequien, P | 1 |
1 other study available for hydralazine and ACD-MPV
| Article | Year |
|---|---|
Neonatal hypertension and thrombosis of the ductus arteriosus.
Topics: Acebutolol; Captopril; Child, Preschool; Ductus Arteriosus; Female; Follow-Up Studies; Humans; Hydra | 1991 |